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Biological vascular systems contain a network of three-dimensional channels that transport and deliver 
necessary nutrients throughout the organism. These systems are complex, adaptable, and possess the 
ability to detect and respond to external stimuli as needed. In this work, we mimic the complexity and 
adaptability of biological systems by incorporating vascular systems into polymeric materials. Vacant 
channels are created using a fugitive ink technique along with 3D gel printing. Upon completion of 
vascular channel construction, proof of principle testing is performed by inoculating the polymeric 
surface with bacteria and adding antibiotics to the vascular channels. The system is then characterized by 
measuring the resultant areas of inhibition. Computer models are constructed in COMOSL Multiphysics. 
The vascular system geometry, antibiotic concentration, and effective diffusion coefficients define the 
model, and are used in conjunction with known bacterial growth parameters such as minimum inhibitory 
concentration and critical time to determine the final arrangement of bacterial biofilm on the surface. 
Theoretical models are then experimentally validated. This approach may prove useful in applications 
such as compact methods of bacterial detection and separation of bacterial multi-cultures based on 
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INTRODUCTION AND LITERATURE REVIEW 
1.1 Thesis Perspective and Overview 
Many variations of functional surfaces aimed at achieving a more automated response to various 
environmental conditions have been established, all with a common goal: achieving greater control over 
the system. Tunable cell culture platforms have been created to aid in cellular adhesion by simply 
responding to external stimuli1–5. Controlled drug delivery systems have been created to tailor drug 
release spatially and temporally throughout the body.6,7 Gradient generators have been created to study 
the effects of chemical gradients on biological systems in vitro.8–11 
Most recently “smart” materials and surfaces have been created through the inspiration of complex 
biological systems in nature. Vascular systems, for example contain a network of three-dimensional 
channels that transport and deliver necessary nutrients and signaling molecules throughout an organism 
resulting in the ability to detect and respond to external stimuli. Vascular systems have been incorporated 
in materials to yield highly desirable self-healing12 and cleaning surfaces.13 Vascular systems have also 
been incorporated into various tissue engineering applications. The ability to seamlessly create these 
vascular channels is attributed to the recent advances in 3D printing technologies.  
In this research, vascular systems are incorporated into an agar platform to easily create arbitrarily 
controlled surface patterning. Our system is unlike current bacterial cell culturing techniques where 
bioactive compounds are applied onto the agar surface or homogeneously mixed into the agar itself. 
Using bacteria as a model organism and antibiotics as a bioactive compound, temporal and spatial control 
of biofilm formation is achievable by coupling our approach with theoretical modeling that allows us to 
design and predict a priori biological response. Vascular channels are embedded into agar and channels 




1.2 Objectives of This Study 
The purpose of this work is to create a vascularized bacterial cell culturing platform that is able to control 
the growth patterns of bacteria at an interface. This platform will control the bacterial coverage on the 
surface though spatial and temporal control of bioactive compound delivery from the embedded vascular 
channels to the surface through diffusion. Theoretical modeling will be coupled with experimental results 
ultimately allowing for behavior prediction of more complex vasculature.  
1.3 Literature Review 
1.3.1 Using Stimuli-Responsive and Tunable Surfaces in Biomedical Research 
The ability to mimic biological conditions in vitro is an important step in understanding how a complex 
biological system operates. By creating compact benchtop systems that closely mimic physiological 
conditions, researchers gain the ability to study smaller portions of a biological process without the 
complications of the many other simultaneous processes. First, the creation of specialized materials that 
are able to mimic these specific biological conditions are necessary. There are numerous applications 
where materials are tuned to mimic biological systems such as tissue engineering constructs, smart 
materials, and gradient generators. These applications will be discussed below. 
1.3.1.1 Tissue Engineering Constructs 
Vascular channels are essential in complex and multi-layer tissue engineering constructs. This approach 
may also hold the key to eventual self-repair of injured tissue constructs. Vascular channels are crucial 
due to their function of transporting blood and necessary nutrients throughout a tissue while removing 
waste products. Vascular systems are also key in injury repair. Cells must be within 100-200 μm of an 
oxygen supply to maintain viability.14 It has been noted that there are significant differences in cell 
behavior between in vitro 2D and 3D culture systems as 3D systems produce much more in vivo-like 
morphologies and behaviors.15 These observations have led to the incorporation of vasculature into in 
vitro 3D tissue engineering models that are more similar to the actual systems rather than being limited in 




Common construction methods of the vasculature lumen include micromolding16 and more recently, 3D 
printing fugitive ink techniques with materials such as Pluronic F127 (PF127)13,17, gelatin18, and 
carbohydrate glass.19 These vascularized tissue constructs have proven useful in areas including the study 
of drug delivery and tumors for cancer research20 as well as the construction of cardiac tissues.21 The 
incorporation of vascular systems into biomaterials allows for more dynamic and stimuli-responsive 
materials. 
1.3.1.2 Smart Materials 
The development of stimuli-responsive materials has led to a whole new class of materials termed 
“smart” materials. These materials incorporate surface functionalization or patterning ultimately allowing 
for the passive response to external stimuli. Examples of smart materials include tunable cell culture 
platforms, which have been created to aid in cellular adhesion by simply responding to external stimuli, 
such as heat1, light2, pH3, electric4, magnetic fields5, and mechanical forces5 For example, 
photoremovable protecting groups of which are attached to the active site of a biomolecule to inhibit 
activity, can be photocleaved through exposure to light resulting in restored function.2  
Smart materials in the realm of controlled drug delivery are also of great interest. There are many 
advantages to a controlled drug release system as opposed to a traditional periodic injection of 
medication. For example, periodic injections of a drug require administration at specified time intervals. 
These treatments are only within the effective therapeutic drug concentration window for a period of time 
and otherwise decrease below this until the next treatment. Controlled released systems on the other hand 
are able to be tuned so that the release rate matches the elimination rate, eliminating the need for periodic 
treatments and time below sub-therapeutic drug level.6 In addition to creating a stable drug profile, these 
systems can also be tuned to deliver drugs to specific locations by creating pH responsive hydrogels7, for 
example. The incorporation of techniques employed by controlled drug delivery systems provide much 
promise in the ability to tune bioactive compound delivery in pursuit of next generation stimuli 




Some smart materials are inspired by biological systems. For example, vascular systems contain a 
network of 3-dimensional channels that transport and deliver necessary nutrients and signaling molecules 
throughout an organism, ultimately resulting in the ability to detect and respond to external stimuli. 
Vascular systems have been incorporated into materials to yield highly desirable self-healing12 and 
antifouling13 properties. Self-healing surfaces mimic the repair of human skin upon damage using epoxy 
and its corresponding healing agent dicyclopentadiene (DCPD). When a crack is formed in the epoxy 
coating, microvascular channels supply the healing agent to repair the crack.12 Antifouling surfaces 
employ polydimethylsiloxane (PDMS) with silicone oil inserted into the vascular channels. These self-
replenishing vascular systems possess unique surface properties which have been shown to reduce the 
adhesion of fouling organisms to surfaces without the need for antibiotics or toxic chemicals. Fouling 
organisms are able to be removed from this fouling-release surface with low hydrodynamic forces.13 
Recent advancements in these stimuli-responsive materials are promising, yet still possess many 
limitations as they are highly complex and specific resulting in stimuli responses too limited for practical 
applications.22 For example, photoremovable groups that inhibit cell adhesion can be photocleaved 
through exposure to light resulting in restored function; however, this material requires complex chemical 
reactions to prepare and once photocleavage occurs it is not reversible.2 
1.3.1.3 Gradient Generators 
Chemical gradients and their ability to influence cellular behavior is well established in biology. 
Examples include embryonic development,23 inflammatory response,24 cancer  development,25 and 
bacterial chemotaxis.26 Understanding how chemical gradients play a role in the developmental and 
homeostatic stages of life is very important. Due to the difficulty to isolate processes in vivo, devices that 
generate gradients have been developed for use in benchtop studies.8–11 
Microfluidic gradient generators are most commonly constructed out of PDMS due to its biocompatibility 
and oxygen permeabilty.27,28 As outlined in a review of microfluidic gradient devices by Kim et al,9 there 




deliver the molecules of interest to the gradient forming region where as flow-based systems rely on 
convective transport. A source and sink are used to create a stable and consistent gradient. Flow-based 
systems may consist of multiple inlets of different solutions that exhibit laminar flow. Diffusive mixing 
occurs between the solutions as it travels through the microfluidic channels. Flow-based generators are 
advantageous as they have the ability to rapidly create/change gradient profiles; however, they exhibit 
many limitations due to the shear stress created by the fluid flow, something that is non-existent in 
diffusion-based systems.  
Flow-based generators are dynamic in nature in that the concentrations and compounds are easily able to 
be changed. The final outlet gradients can easily be adjusted by simply changing the number, location, 
and velocities of the inlets. A major motivation for using flow-based generators is their ability to simulate 
in vivo environments where flow-induced shear stresses traditionally occur. Flow-based generators have 
even made it possible to generate gradients formed through pulsatile release of chemicals.29 Wound 
healing assays with tunable cell shear stresses (ideal for mimicking physiological conditions)30 and 
chemotaxis assays26 have also been studied. One disadvantage of these systems is the potential for 
disruption of normal cellular migration and possible convection influences on migration, making these 
gradient generator methods only suitable for adherent cell types.9,28 
Considering the nature of diffusion-based systems they are vastly different from flow-based systems and 
have the potential for many different applications. They are ideal in cases where convection may cause 
unwanted shear stress or movement of cells. Depending on the application of this system it may or may 
not be ideal to have a steady gradient. If a steady gradient is necessary, a source-sink design will need to 
be used. In designs with static reservoirs unsteady diffusion profiles are generated because as diffusion 
occurs boundary conditions are altered.31 The addition of a source and sink will allow for a more 
controlled and stable gradient.9,28 The creation of gradient generators has enabled in vitro studies 
investigating cell behavior responses to chemical gradients by mimicking biological gradients with 




1.3.1.3.1 Diffusive Mass Transport 
In order to create a controlled diffusive chemical gradient mass transport must take place through 
diffusion. Driving forces of diffusion are concentration gradients. When quantifying mass transport, a 
useful term is the flux. Flux (mol m-2 s-1) quantifies the amount of a material being transported over a 
given area and time. In cases where additional modes of mass transport such as convection and migration 
contribute to overall flux, each flux will be summed together to determine the overall flux in the system. 
The simplest of all cases is Fickian diffusion, it describes solute motion due to concentration gradients. 
The solute and the material through which the diffusion is occurring have no chemical or physical 
interactions that may influence the diffusion process.32–34 In some cases physical changes such as swelling 
of a hydrogel matrix may also influence diffusion.7,35–37 Additionally, electrostatic and ionic interactions 
between species and material of which diffusion is occurring, may be present.38  
The simplest case of Fickian diffusion occurs when the system is at steady state and the solute 
concentration does not change over time, this is known as Fick’s First Law: 
𝐍𝑖 = −𝐷𝑖∇𝑐𝑖 (1) 
 
where for species i, 𝐍𝑖 is the molar flux (mol m
-2 s-1), 𝐷𝑖 is the diffusion coefficient (m
2 s-1), and 𝑐𝑖 is the 
concentration gradient (mol m-3). Using the continuity equation for mass: 
𝜕𝑐𝑖
𝜕𝑡
+ ∇ ∙ 𝐍𝑖 = 0 (2) 
 
where t is time (s), Fick’s first law can be further modified to account for non-steady state diffusion where 







Fickian diffusion assumes the diffusion coefficient to be constant at a given pressure, temperature, and 





1.3.2 Microfluidic Device Fabrication 
Fluidic channels are most often made through molding of PDMS and other polymers.13,16,40 However, a 
fugitive ink technique was recently introduced to allow the direct 3D printing of support material in a 
solid material that is easily removed resulting in vacant channels.17 Fugitive ink techniques use sacrificial 
materials during the printing process that can later be removed resulting in vacant channels. Some of the 
most common sacrificial materials include PF12713,17, gelatin16, carbohydrate glass19, and microcrystalline 
wax.41 These materials can be removed from the inside of the matrix material. PF127 can be printed and 
then removed due to its thermally reversible gelation. 42 At warm temperatures, above 10 ˚C, the PF127 
will gel and as it cools back below 10 ˚C it will liquefy allowing for removal from a 3D printed vascular 
network. Gelatin can easily be removed by simply raising the temperature above 37˚C.43 
The most common 3D bioprinting techniques deposit one layer at a time and include inkjet, extrusion, 
and laser.44 There are two types of 3D inkjet printing: thermal and acoustic. Thermal inkjet printers heat 
the print head to produce air pressure pulses forcing droplets from the nozzle while acoustic printers 
produce pulses from ultrasound pressure or a piezoelectric actuator.44 Prints can be cured through 
chemical or photo-crosslinking methods. There are several advantages of inkjet printing including the 
ability to use liquid or powder support materials. This makes it very simple to remove these materials 
from the final structure. Inkjet printing also exhibits high printing speeds and a high resolution compared 
to extrusion and laser printing. Another notable difference between inkjet as opposed to extrusion and 
laser printers is the low material viscosity range of 3.5-12mPa/s. An example of inkjet printing is the 
deposition of alginate droplets into a bath of calcium chloride.43 The calcium chloride bath acts as an 
ionic cross-linker as well as a liquid support.  
Extrusion printing has a mechanical or pneumatic dispensing system that deposits material in a 
continuous flow. Extrusion printing methods are among the cheapest, simplest, and most versatile. Unlike 
inkjet and laser printing chemical and photo-crosslinking techniques are not always required and a simple 




printing. Common examples of extrusion printing with fugitive techniques include networks printing in 
polymeric matrix with PF12717 and collagen scaffolds with sacrificial gelatin.45  
Laser printing is significantly less common than inkjet and extrusion most likely due to its complexity. 
Laser printing has only recently been gaining popularity. Lasers are focused on an absorbing substrate in 
order to generate pressures that propel printing materials onto a collector substrate.44 Lasers can also be 
used for very high resolution polymerization of a monomer solution.46 
1.3.3 Conclusions 
In the recent years there has been much progress in the development of stimuli-responsive and tunable 
materials. Advancements in 3D printing technologies have allowed for automated fabrication through 
CAD software with new materials at greater precision and resolution.44 The development of these 
materials has allowed for greater ability to simulate in vivo environments and mimic physiological 
conditions. The incorporation of vascular systems into biomaterials has allowed for the creation of 3D 
culture systems resulting in much more in vivo-like cell morphologies and behaviors.15 Vascular systems 
have also enabled the transportation of signaling molecules necessary for stimuli-responsive materials.12 
Functionalized surfaces have allowed for response to external stimuli.1–5 Controlled drug delivery systems 
enable for customization of drug delivery. Gradient generators have enabled the creation of benchtop 
models to study the effects of chemical gradients of many biological processes.23–26 However, there are 
many limitations with the current stimuli-responsive biomaterial technology. Functional and patterned 
surfaces are highly complex resulting in stimuli responses to limited for practical applications. Many of 






2.1 Microbial Methodology 
2.1.1 Microbial Strain Information 
The bacterial strains used in this work were Escherichia coli K12 W3110 (wild type) CGSC # 4474 
obtained from Yale Stock Center, Staphylococcus epidermidis 1200 ATCC 12228 obtained from 
American Type Culture Collection, Escherichia coli pBBR MCS-5 (GFP) obtained from Massachusetts 
Institute of Technology Ribbeck laboratory, and Bacillus subtilis MTC 871 (3610sacA::Phag-mKate2 
[KanR] amyE::PtapA-cfp [SpcR] ywrK::PsspB-citrus [CmR]) provided by the Losick laboratory of 
Harvard University. Gentamicin resistance is expressed in E. coli (GFP) and a resistance to kanamycin is 
expressed in B. subtilis.  
2.1.2 Microbial Growth Media 
For suspended, liquid-based growth tryptic soy broth (TSB) and Miller’s Luria-Bertani (LB) broth were 
used. TSB and LB were added at a concentration of 0.025 g/mL to DI water. For growth in petri dishes, 
0.03 g/mL TSB and 0.015 g/mL bacto agar was used to make tryptic soy agar (TSA) and 0.025g/mL LB 
and 0.015 g/mL bacto agar to make LB agar. Once mixed, all liquid and agar media were subject to 
autoclave sterilization at 121 ˚C for 60 minutes. Once the agar had cooled to touch it was poured into petri 
dishes. The average volume for square petri dishes was 30mL and the volume for circular petri dishes 25 
mL. Once the agar dishes cured, they were stored at 4 ˚C until used.  
When making plates of E. coli GFP and B. subtilis antibiotics were added following sterilization to select 
for the antibiotic resistance genotypes. Following addition of antibiotics, the media was subjected to 




2.1.3 Microbial Growth Methods 
All bacteria were maintained as freezer stocks at -80 ˚C and grown via quadrant streak plates on either 
1.5% Miller’s Luria-Bertani (LB) agar or 1.5% tryptic soy agar (TSA) at 37 ˚C for 18 to 24 hours. Stock 
cultures were stored at 4 ˚C for no longer than two weeks before they were re-streaked to avoid 
contamination and mutations.  
2.1.3.1 Overnight Stock Solutions 
Overnight stock solutions were made by adding 3 mL of either tryptic soy broth (TSB) or LB broth to a 
vented test tube. Approximately 2-3 colonies were taken from a 4 ˚C stock and transferred to the test tube 
via sterile wooden applicators and placed in the incubator for 18 to 24 hours. The turbidity of the sample 
was adjusted by diluting with either TSB or LB to achieve an optical density (OD) of about 0.08 – 0.1 A 
at 600 nm. 
2.1.3.2 Direct Colony Suspension Method 
Isolated colonies were taken from an 18 to 24 hour quadrant streak plate. The isolated colonies were 
inserted directly into a liquid suspension containing 1x phosphate buffer solution (PBS). The turbidity of 
the sample was adjusted by diluting with 1x PBS to achieve an OD of about 0.08 – 0.1 A at 600 nm. 
2.2 Antibiotics 
Antibiotics used in this work include gentamicin sulfate (Sigma-Aldrich G1264) and kanamycin sulfate 
(Sigma-Aldrich K-4000). Stock solutions of 10 mg/mL of antibiotics were created using sterile DI water 
and mixing thoroughly with a vortex mixer. Antibiotic stock solutions were stored at 4 ˚C for no longer 
than two weeks. When making stock solutions of E. coli GFP and B. subtilis, gentamicin sulfate and 
kanamycin sulfate were added at concentrations of 5 μg/mL and 100 μg/mL, respectively.  
Gentamicin sulfate and kanamycin sulfate are both broad spectrum aminoglycoside antibiotics which 
operate by the same mechanism of action: inhibition of protein synthesis. Aminoglycosides bind to the 




incorrect insertion of amino acids into the resulting polypeptide. Due to their interruption of protein 
synthesis, aminoglycosides exhibit bactericidal activity.48 It has also been noted that energy is required for 





FABRICATION OF EXPERIMENTAL COMPOUND DELIVERY SYSTEMS 
3.1 Construction of Vascular Systems 
3.1.1 3D Printers 
3.1.1.1 Homemade 3D Printer 
Our homemade 3D printer was assembled by Tom Blough of Wyss Institute at Harvard University and 
was graciously gifted to the University of Maine Howell laboratory. This printer pictured in Figure 3.1 
was used in the early stages of this study; however, it was noted that there were many limitations 
associated with the use of this printer. This printer had a relatively small printing stage that was only able 
to move in the XY directions. An independently run syringe pump was used to control the flow of the 
printing material causing many problems, with the first being that it was extremely difficult to precisely 
coordinate the movement of the printing bed with the extrusion of the material. Since the syringe pump 
was not integrated into the printing system itself it was nearly impossible to print designs that were not 
continuous. The other major problem encountered while using this printer was the inability to control the 
temperatures of the printer bed, extruder, and the printing environment; temperature control is critical in a 
pluronic-based printing process, as well as with other temperature sensitive materials. Additionally, this 
printer was only capable of reading GCodes, meaning more preparation work in preparing a file to be 
printed. To address these issues the use of more advanced printers was investigated. 
3.1.1.2 Hyrel System 30M Printer 
The Hyrel System 30M printer was used to 3D print the vascular channels that lie within the compound 
delivery systems. This printer has many advantages over the homemade 3D printer. With the combination 
of a completely enclosed printing environment, a heated printing bed, and a variety of specialized 
temperature-controlled extruders, the printing process was able to be completely temperature controlled. 
In addition to the temperature-controlled printing environment this printer was also capable of printing in 




coordinated with one another allowing for much more complex prints as compared to the homemade 
printer. This system and its software are capable of reading multiple format types including GCode and 
STL files. Below a comparison of the two printers discussed can be viewed in Figure 3.1. 
 
3.1.2 GCode 
A GCode file is a numerical control programming language mainly used for computer-aided 
manufacturing to control automatic machine tools; in this case, a 3D printer. This file contains all 
information regarding the print, including printing and non-printing moves and other background 
information. Printing moves include each individual movement that happens while printing and non-
printing moves include times when the extruder is moving, but not printing. Other background 
information frequently adjusted includes size of extrusion nozzle, printing speed, and temperature. Prior 
to all printing information lies a printing command, an uppercase letter and number followed by a space. 
An example of a GCode can be seen in Figure 3.2. 
 
Figure 3.1. Comparison of Homemade 3D Printer and Hyrel System 30M 3D printer. (A) The 
simple and operationally limited homemade 3D printer. (B) the Hyrel System 30M 3D printer which 






For simple straight-line geometries, GCodes are the preferable file type for printing due to their 
simplicity. After initial generation of a GCode file that includes printer parameters through the Hyrel 
software, coordinates can easily be altered for additional geometries. It is important to note that for 
anything more complex, such as a circle, this method of manually entering coordinates is not practical. 
3.1.3 MATLAB GCode Generation 
When printing line geometry of more complex shapes such as circles or sine-waves a MATLAB code was 
created to generate the printing move coordinates in an automated fashion. 
 
Figure 3.2. GCode File. Printing commands contain an uppercase letter and a number followed by a 
space and are most frequently at the beginning of each row. Examples of commands are outlined with 
blue boxes. Printing information such as coordinates (X111.49 Y52.294), amount of material 





3.1.4 CAD Files 
If the desired vascular channel is more complex than that of a single line or equations, CAD files were 
created using Solidworks. An example of when a CAD file is more convenient to construct than a GCode 
is when the shape itself is thicker than the extrusion nozzle and will require more than 1 layer.  
Following completion of the CAD file it can easily be converted into an STL file, which the Hyrel 3D 
printer is able to read. STL files are traditionally used for rapid prototyping, 3D printing and compute-
aided manufacturing. In order to 3D print it must be used in conjunction with a 3D slicer software – this is 
built into the Hyrel System 30M printing software.  In the 3D slicer, the surface geometry for each 
individual layer is stored, resulting in a 3D 
printing process that is performed layer by layer. 
Figure 3.3 displays an example of the University 
of Maine Logo CAD file that was ultimately 
converted to an STL and printed. 
3.2 Three-Dimensional Gel Printing  
3.2.1 Agar Platforms 
In this research, fabrication methods for two types of systems were developed. The goal of the first 
system was to achieve spatial control of compound delivery to the surface of the system by varying the 
placement of the channels. The second, the ability to achieve temporal control of compound delivery to 
the surface by varying the depths of the channels within the agar itself.  
3.2.1.1 Spatial Control 
Vascular channels were created by 3D printing 30% (w/v) PF127 channels directly onto the surface of a 
100 x 100 x 15 mm polystyrene petri dish at 25˚C with a 15-gauge blunt tipped needle. A mass of 35g 
Miller’s LB agar at 4% (w/v) cooled to touch was then poured over the PF127 channels and left to cure at 
room temperature. Inlet and outlet holes were then melted into the bottom of the petri dish using a 15-
gauge blunt tipped needle to allow for removal of PF127. Channels were then rinsed with DI water. With 
 
Figure 3.3. CAD File. University of Maine logo 





an n of 3, the agar thickness was determined to be 3.84 mm with a standard deviation of 0.25 mm. The 
channels were approximately semicircular in shape with a width of 1.83 mm and height of 1.12 mm with 
standard deviations of 0.56 and 0.12 mm, respectively. Figure 3.4. demonstrates the printing process. The 
resultant spatial control patterns of varying complexity achieved through this printing process can be seen 
in Figure 3.5. 
 
3.2.1.2 Temporal Control  
By varying the depths of the vasculature within the compound delivery system, temporal control of 
compound delivery to the surface was achieved. The 3D printing process started off similar to that of the 
spatial control procedure, the first and deepest channel was printed directly onto the surface of the petri 
dish using 30% (w/v) PF127. A mass of 35g Miller’s LB agar at 4% (w/v) was then poured over the 
channel and let left to cure half 
way. Another channel was then 
printed directly onto the surface of 
the half-cured agar and then more 
 
Figure 3.4. 3D Printing Process in Agar. (A) vascular Channels are printed directly onto the surface 
of a petri dish, (B) encapsulation of the vasculature is achieved by pouring liquified agar on top of the 
gel channel, (C) agar is cured, (D) gel is removed through liquification of the PF127 gel.  
A B C D
 
Figure 3.5. Spatial Control Patterns.  
 






agar poured over the top. This process was repeated until the desired number of channels and thickness of 
agar was achieved. In Figure 3.6. an image of agar with channels of varying depths can be seen. 
3.2.2 Troubleshooting  
To avoid gaps in the printed channels, it was critical to remove all air from the PF127 prior to printing. 
This was accomplished by adding the liquified PF127 directly from 4 ˚C storage into the printing metal 
syringe and then removing air bubbles by inserting the metal syringe into a vacuum chamber. Next, the 
syringe was placed in a 70 ˚C oven for approximately five minutes to allow for gelation. Gelation prior to 
inserting into the printer is important because this material is prone to foaming when subjected to 
movement.   
PF127 was found to be highly sensitive to temperature differences. For example, when the printing 
environment was below 10 ˚C, liquification would occur, resulting in the loss of structural integrity of the 
channels during the printing process, as seen in Figure 3.7A. Structural integrity of the printed channels 
was accomplished by ensuring that on cold days the 
printer head was set at 25-30 ˚C and the gel 
channels were stored in the enclosed printer 
structure on the heated bed at 30 ˚C. Another 
example of loss of structural integrity was observed 
when the agar used to encapsulate the channels was 
too hot (Figure 3.7B). In this case, structural 
integrity of the channels was accomplished with a 
lower molten agar temperature. Additionally, it was noted that after pouring the agar over the channels 
and stacking the dishes to let cure, air bubbles trapped within the PF127 rose to the surface causing 
openings in the channels. This was solved by letting the dishes cool individually instead of stacking them. 
Ideally, the agar should be cooled as fast as possible and when the plates were stacked the cooling process 
was slowed.  
 
Figure 3.7. Fabrication Troubleshooting. 
Structural integrity loss due to (A) low air 







CHARACTERIZATION OF VASCULARIZED ANTIBIOTIC DELIVERY SYSTEMS 
4.1 Introduction 
Proof of principle testing of the agar-based spatially-controlled antibiotic delivery systems were 
performed using the bacteria E. coli K12 and S. epidermidis along with the antibiotic gentamicin sulfate. 
In order to characterize the system three important parameters have been quantified; inhibition zone, 
minimum inhibitory concentration, and critical time. The inhibition zone is the distance from the edge of 
the channels to the point at which bacterial growth occurs visually with the naked eye. The critical 
concentration at which no bacterial growth 
occurs is termed the minimum inhibitory 
concentration (MIC). The time at which the 
inhibition zone forms is referred to as the 
critical time. Antibiotics must reach the 
bacteria prior to the critical time in order for 
an inhibition zone to be formed. Critical 
times will be dependent on a multitude of 
factors including seed density and growth 
temperature, for E. coli the expected time 
range should be within three to five hours.50 
A graphical representation of the relationship 
between critical time and MIC to the bacterial growth curve can be seen in Figure 4.1. As depicted in this 
figure, the critical time occurs soon after the transition from the lag to exponential growth phase, resulting 
in visualization of growth. Additionally, an inhibition zone will only be present if the MIC is achieved 
prior to critical time.  
 
Figure 4.1. Relationship of Critical Time and MIC 
to Bacterial Growth Curve. The red box indicates the 
time and concentration conditions where no bacterial 




 In this chapter the methods by which the minimum inhibitory concentration (MIC), inhibition zone, and 
critical time parameters were determined are presented, followed by the interpretation of results. The 
influence of evaporation on the antibiotics on the channel openings was also investigated. 
These methods were created based off of currently accepted techniques published by the Clinical 
Laboratory Standards Institute (CLSI). Inhibition zone test method ideas were taken from the published 
Kirby-Bauer disk diffusion test methods, which enable researchers to determine the level of antibiotic 
susceptibility of individuals organisms. This test used a standard Mueller-Hinton agar plate streaked for 
confluent growth. Six-millimeter filter paper disks impregnated with antibiotics were placed onto the 
surface of the agar and placed in an incubator for 16 to 18 hours at 35 ˚C. The inhibition zone diameter 
was measured from edge to edge and rounded up to the nearest millimeter. Performance standards 
published by CLSI can then be used to determine the susceptibility, either resistant, intermediate, or 
susceptible.51,52 The final parameter of interest in antibiotic susceptibility testing is the minimum 
inhibitory concentration (MIC), the concentration of antibiotic at which visible growth of the bacteria of 
interest is inhibited. This parameter is used to determine if a pure culture has been contaminated or has 
experienced mutations from the wild type.53 
4.2 Materials and Methods 
4.2.1 Inhibition Zone 
First, multiple agar vascular channel systems were prepared according to the procedures described in 
Chapter 3. Agar plates were streaked for confluent growth with a single bacterial species using a sterile 
cotton tipped applicator. The lid was then placed on the petri dish and it was flipped over so that the 
channel inlets and outlets on the bottom of the dish were facing up. Various concentrations ranging from 
20 μg/mL to 100 μg/mL antibiotics were prepared. Lastly, the antibiotics were added to the channels 
using a pipettor. Each plate received a different antibiotic concentration so that a dose response curve 
could be constructed. The plates were incubated at 37 ˚C overnight for approximately 18 to 24 hours. 




inhibition zone was determined by measuring the distance between the edge of the channel and the 
inhibition zone. At least ten measurements were taken for each channel measured. 
4.2.2 Minimum Inhibitory Concentration 
Two methods were used to determine the MIC. The original method used for determining MIC was the 
agar plate method. Here, 1.5% agar was prepared and following sterilization the agar was divided into 
various 25 mL aliquots. Each aliquot was dosed with a different concentration of antibiotic and 
thoroughly mixed using a magnetic stir bar and plate. The agar aliquots were then poured into their 
respective petri dish and left to cure. The plates were then streaked for confluent growth with bacteria 
using a sterile cotton tipped applicator and placed at 37 ˚C for 18 to 24 hours. The MIC was determined 
by identifying the plate with the lowest concentration of antibiotic that was found to completely inhibit 
the growth of the bacteria.  
The second method used was the microplate broth dilution. For this method a 96 well plate is used. Each 
well contained equal volumes (50 μL) of antibiotic, bacterial growth media, and an overnight stock 
solution of bacteria. Varying concentrations of antibiotics were added to each well. The OD at 600 nm 
was then recorded. Following the first OD reading, the 96 well plate was incubated on a shaker for 
approximately 18 to 24 hours. Following incubation, the OD was taken again. The difference in OD was 
then obtained by subtracting the initial OD from the final OD. The antibiotic concentration that results in 
a difference of zero, resulting in no bacterial growth, was identified as the MIC. The MIC was measured 
for E. coli wt , E. coli GFP, and S. epidermidis. Each MIC experiment was performed in triplicate. Two 
controls were included in these experiments. The first control had growth media, bacteria and PBS which 
was in place of the antibiotics. The second control contained only growth media and PBS which was 
substituted in place of the bacteria and antibiotics. 
4.2.3 Critical Time 
Agar plates were streaked for confluent growth with a single bacterial species using a sterile cotton tipped 




and outlets were facing up. Plates were labeled 1 to n (the number of total plates, at least 5). A 
concentration of 50 μg/mL gentamicin antibiotic was added to the channel(s) of plate 1 and the time was 
recorded. All plates were then placed in the incubator at 37 ˚C. The total number of plates were divided 
up by approximately 6 hours. At the calculated time increment, plate 2 was removed from the incubator 
and 50 μg/mL gentamicin antibiotic was added to the channel(s) and then the plate placed back into the 
incubator. Time of antibiotic addition recorded was recorded. This procedure was repeated until 
antibiotics were added to all plates. The plates were stored in the incubator for a total of 18 to 24 hours. 
Upon completion of incubation, photos were taken of the inhibition zones which were then measured in 
ImageJ.  
The determination of critical time was achieved through plotting the inhibition zone squared against the 
preincubation time and then identifying the x-intercept of the corresponding linear regression line. This 
method, published by Cooper and Woodman54 assumed a linear diffusion gradient and a constant 








where y is the distance from the reservoir (mm), C is the concentration (ug/mL) at distance y, C0 is the 
concentration in the reservoir (ug mL-1), D is the diffusion coefficient (mm2 hr-1), and T is the elapsed 
time in hours. For the experiments presented in this thesis, this same relationship was assumed to be true. 
It is possible that the differences of an emptying reservoir altered the squared relationship, however the 
differences were assumed to be negligible as the concentration gradient that affected the bacteria occurred 
within the first few hours prior to the channels emptying. 
4.2.4 Evaporation 
In order to determine if evaporation was influencing the action of the antibiotics three identical plates, 
each with three channels, were constructed. The plates were all streaked for confluent growth with E. coli 




underwent a different treatment following addition of the antibiotics. For treatment 2G, both the inlet and 
outlet were sealed off with vacuum grease. For treatment 1G, one of the inlet/outlet holes was sealed with 
vacuum grease. For the third treatment, 0G, the inlet and outlet were left open. The plates were then 
incubated at 37 ˚C overnight for 18 to 24 hours. Following completion of incubation, the plates were 
imaged and the inhibition zones measured in ImageJ. Twenty measurements were taken for each channel. 
4.3 Results 
4.3.1 Inhibition Zone 
Figure 4.2 shows the relationship between observed inhibition zone at varying antibiotic concentrations. 
The observed dose-response relationship followed a distinct logarithmic relationship. Four replicates were 
performed for S. epidermidis and six for E. coli K12. A table of the individual averages for each 
concentration and its corresponding standard deviation can be found in Appendix A.  
 
 
Figure 4.2. Inhibition Zones. (A) S. epidermidis and (B) E. coli K12 where i) displays inhibition 
zones observed at varying antibiotic concentrations from channel side down and ii) dose-response 
























































In Figure 4.3 the inhibition zones as seen by the unaided eye and with fluorescence microscopy of E. coli 
GFP can be seen. The inhibition zone from image A) measured by the unaided eye is 4.85mm, C) 
microscopy image with low threshold was 1.26 mm and D) microscopy image with high threshold was 
5.51 mm.  
4.3.2 Minimum Inhibitory Concentration 
Experiments performed using the agar plate method yielded inconsistent results despite numerous 
replicates; the raw data can be found in Appendix A. Figure 4.4 shows the results from the microplate 
broth dilution MIC experiment. The graph displays the difference in OD from the start, when the bacteria 
and antibiotics are added, to the end following 18 to 24 hours of incubation. An OD difference of zero 
indicates no bacterial growth. Experimental results indicated that the MIC for E. coli K12 was 1.5 ug/mL 
and E. coli GFP, 4 ug/mL. The MIC results for S. epidermidis were inconclusive. The controls indicated 
contamination as there shouldn’t have been growth.  
 
Figure 4.3. E. coli GFP Inhibition Zone. (A) Results from unaided eye with inhibition zone of 
4.85mm, (B) results from fluorescence microscopy, (C) superimposed yellow border of a software 
generated low threshold inhibition zone measured to be 1.26 mm, (D superimposed yellow border of 
a software generated high threshold inhibition zone measured to be 5.51 mm. (E) Gray scale values 
of image B from left to right of image. 
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4.3.3 Critical Time 
To reiterate, the critical time was the time at which the antibiotics were required to reach the bacteria in 
order for a distinct inhibition zone to be formed. The Five replicates of the critical time experiment were 
conducted for S. epidermidis and E. coli K12. The average critical times for S. epidermidis and E. coli 
K12 were 363 and 343 minutes with standard deviations of ±50 and ±37 minutes, respectively. Figure 4.5. 
shows the results of a single critical time experiment. With the inhibition zone squared vs. the time at 
which the antibiotics were added to the plates. A linear function was fit to the data to extrapolate the x-
intercept, which indicated the critical time at which the addition of antibiotics did not influence the 
inhibition zone. Data from each individual trial and bacterial strain can be found in Appendix A.  
 
Figure 4.4. Minimum Inhibitory Concentration Microplate Broth Dilution. Growth (change in 





























Using the Mann-Whitney U-test in Minitab software, it was concluded that with 95% confidence there 
was no statistical difference between the median inhibition zones of the channels with the different 
treatments (Figure 4.6). Raw data and P values can be found in Appendix A.  
4.4 Discussion and Conclusions 
4.4.1 Inhibition Zone 
Dose response curves were successfully generated for S. 
epidermidis and E. coli K12 with acceptable standard 
deviations, especially when taking into consideration the 
relatively large variation inherent in biological systems. To get 
a better understanding of the inhibition zone, the differences in 
the zones from the unaided eye and fluorescence microscopy 
of two varying thresholds must be further investigated.  
 
Figure 4.5. Critical Time. (A) Graph used to determine critical time and (B) observed inhibition 
zones of E. coli K12. 





























Figure 4.6. Evaporation. 2G 
indicates grease sealing both inlet 
and outlet, 1G indicates sealing one, 





4.4.2 Minimum Inhibitory Concentration 
The results from the agar plate method were inconsistent despite numerous replicates and improvements 
upon the experimental procedure. Initially, inconsistencies were believed to be due to the insufficient 
mixing of the antibiotics in the molten agar itself, but upon improving the mixing procedure results 
remained the same. Another idea was that the heat of the molten agar itself was affecting the antibiotics, 
but after confirmation from manufacturers and literature it was determined that antibiotic effectiveness is 
very minimally altered even when subjected to very high temperatures experienced during the autoclave 
process, which is much greater than the temperature of the agar that was being mixed with. After 
carefully analyzing the colony forming unit (CFU) counts at various antibiotic concentrations from the 
agar plate method, it was noted that the CFUs that were counted were all relatively small counts as 
compared to the initial starting concentration on the order of magnitude of 108 CFU/mL with an estimated 
amount of 5x106 CFU/mL transferred from the swab to the plate. Most observed CFU counts were far less 
than 100, an extremely small fraction compared to the starting CFU counts. These consistently small 
counts may be attributed to probability. The sensitivity of this method indicated that this method may not 
be the best option to use in this circumstance.  
The results from the microplate dilution method proved to be just as inconsistent from trial to trial. A few 
explanations for the variation were that when the initial OD is taken the liquid within the plate is 
homogeneously mixed, but after incubating there are bacterial clumps present when incubated with the 
shaker. The clumps were attempted to be broken up using a vortex mixer but resulted in splashing 
between wells. In order to get more consistent results from this experiment, different equipment will be 
needed such as covers for the 96-well plates and a shaker incubator more suited to a 96 well plate. The 
reason for using two different methods to measure MIC was to ensure that both methods arrived at the 
same conclusions, however; this was not the case.  
 To complicate matters even more the MIC from literature of E. coli ATCC 25922 is 




all of the inconsistencies it was determined that the MIC values published in literature will be used for 
further analysis in order to complete modeling in Chapter 5. 
4.4.3 Critical Time 
The critical times calculated were roughly 6 hours, within the expected values of 4 to 10 hours described 
in literature.56,57 However, upon further investigation it was determined that the critical times discussed in 
literature applied antibiotics to a disk and placed the disk on the surface of the agar where the antibiotics 
diffused onto the surface. Our experiments added antibiotics to channels which then had to diffuse 
through the agar matrix before reaching the surface. Ultimately, it was determined that this difference in 
experimental setup led to incomparable results. We must use alternate methods to interpret these results.  
4.4.4 Evaporation 
It was concluded that there was no statistical difference between the inhibition zone observed with the 
open channels which experienced evaporation and the sealed off channels where the liquid remained in 
the channels. The remaining liquid in the channels did not appear to have an effect on the inhibition zone 
indicating that the remaining liquid in the channels was not the antibiotic solution added at the start of the 





DIFFUSION MODELING OF VASCULARIZED ANTIBIOTIC DELIVERY SYSTEMS 
5.1 Introduction 
Here, we explore the use of COMSOL Multiphysics modeling to calculate the mass transport of antibiotic 
compounds through a bioinspired vascularized polymer system and use this model to predict the growth 
pattern of a bacterial biofilm on the surface of the polymer. Vascular system geometry, antibiotic 
concentration, and diffusion coefficient define the model, and were used in conjunction with known 
bacterial growth parameters such as minimum inhibitory concentration (MIC) and critical time to 
determine the final arrangement of the biofilm on the surface. The theoretical models were then validated 
by comparing to experimental results.  
COMSOL Multiphysics was used to calculate the concentration field of a solution throughout the 
diffusion process and displayed an interactive graphical solution. COMSOL is capable of solving 
stationary and time dependent problems in all space dimensions, but for this application a time dependent 
solver was used along with the transport of diluted species module. When solving this module COMSOL 
assumed that the solution was greater than 90% solvent concentration and that the mixture properties 
(density and viscosity) were of the solvent. COMSOL takes into account three driving forces of transport: 
diffusion, convection, and migration. However, for this case diffusion was the only factor. In order to 
calculate the concentration fields COMSOL used Equation (1), Fick’s First Law in conjunction with the 
mass balance equation:  
𝜕𝑐𝑖
𝜕𝑡
+ ∇ ∙ (−𝐷𝑖∇𝑐𝑖) = 𝑅 (5) 
 
where 𝑅 equals the production or consumption rate expression.  
COMSOL used finite element analysis to solve the simulation. This method approximated partial 
differential equations that are unable to be solved analytically. First, finite element mesh refinement was 
performed. The CAD model was divided into smaller domains (elements), the smaller the elements, the 




method was performed. This method took all the partial differential equations for each individual element 
created in the mesh and solved.  
5.2 Methods 
5.2.1 Fabrication of COMSOL Model 
CAD files of the vascularized polymeric platforms are created in SOLIDWORKS and exported to 
COMSOL Multiphysics using the LiveLink feature. For the 3D printing process, a 15-gauge needle 
(approximately 1.3 mm inner diameter) was used to print the PF127. However, the channel does not 
remain circular upon coming into contact with the petri dish. To determine the actual shape of the channel 
needed to be designed in SolidWorks, cross-sectional areas were cut from constructed vascular systems 
and measured. Here a semicircular channel shape of  radius of 0.9 mm was used. 
In COMSOL a simulation was created using the transport of diluted species physics in a time dependent 
solver. The model assumed Fickian diffusion and 
therefore a constant diffusion coefficient. The 
simulation inputs included diffusion coefficient and 
antibiotic concentrations in both the channels and the 
surrounding agar. A no flux boundary condition for all 
surfaces of the agar was also initiated. Simulation 
outputs included concentration vs. time profiles (Figure 
5.1). Instead of inputting the known diffusion 
coefficient of gentamicin and 4% agar, the apparent 
diffusion coefficient which takes into account for the 
biological aspects of the system was inputted. 
 
Figure 5.1. Schematic of COMSOL 
Simulation Fabrication. A CAD file is 
created in SolidWorks and imported into 
COMSOL, the model is defined and run 
resulting in a concentration vs time profile. 










5.2.2 Using a Model to Create a Predictive System  
Through experiments it was observed that 
with the unaided eye this biological system 
had only two states: a start with no 
bacterial growth and an end with a distinct 
inhibition zone, whereas a COMSOL 
model outputted concentration profiles over 
time as seen in Figure 5.2. 
The ultimate goal of this system is to run an 
experiment with simple vasculature and 
resultant bacterial patterning, characterize 
the system, and create a theoretical model to ultimately predict and control bacteria surface coverage. 
This process is depicted in Figure 5.3.  
This model contains two distinct processes: diffusion of antibiotics to the biointerface and the growth and 
uptake of the antibiotics by the bacteria. Modeling the diffusion of antibiotics to the surface, in our case 
gentamicin sulfate, requires the knowledge of the diffusion coefficient.  
This unknown apparent diffusion coefficient was solved for using the COMSOL simulation. Model inputs 
included an arbitrary diffusion coefficient, antibiotic concentration in channels (20, 40, 50, 60, 80, and 
 
Figure 5.3. Process of Creating a Predictive System. (A) Experimental results from simple 
vasculature are used to create (B) a predictive model, the model is then used to achieve (C) desired 
bacterial coverage ultimately yielding the (D) desired bacterial coverage on more complex 
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Figure 5.2. Comparison of COMSOL Theoretical 
and Experimental Results. (A) COMSOL output with 
















100 ug/mL), and the polymer material initial antibiotic concentration of zero. Experimentally, with each 
individual starting antibiotic concentration a different inhibition zone was observed. The larger the 
antibiotic concentration the larger the zone. The surfaces of the agar for all antibiotic concentrations were 
inoculated with the same number of bacteria at the same time. Here, we assumed that rate of bacterial 
growth between the concentrations was the same, ultimately resulting in inhibition zones being formed at 
the same time: the critical time. As stated in Chapter 4, the inhibition zone is formed at the point where 
the antibiotic concentration equals the minimum inhibitory concentration at the critical time. To 
summarize, it was assumed that the inhibition zone was formed at the same time (critical time) and 
concentration (MIC) for all plates regardless of antibiotic concentration in the channels. Knowing all of 
these parameters the apparent diffusion coefficient, which is expected to be equal for all antibiotic 
concentrations, was solved for. The graphs used to determine the resultant apparent diffusion coefficient 
yielding an intersection between the inhibition zone, MIC, and critical time can be seen in Figure 5.4A. 
The resultant apparent diffusion coefficients can be seen in Figure 5.4B.  
It can be seen that the resultant apparent diffusion coefficients from the fit varied and that the values 
decreased as concentration increased. The resultant apparent diffusion coefficients may be attributed to 
some incorrect assumptions of the model construction. A no flux boundary condition at the surface was 
assumed. However, as mentioned previously, the antibiotics were not all accumulating at the surface, 
 
Figure 5.4. Fitting Apparent Diffusion Coefficient to Inhibition Zone, Critical Time and MIC. 
(A) Graph of surface concentration at the inhibition zone versus time used to approach apparent 





































































some were being consumed by the bacteria. 
The differing diffusion coefficients may also 
be attributed to the fact that the diffusion may 
have been at different stages between 
concentrations (approaching peak 
concentration vs equilibrium) at the critical 
time (Figure 5.5). These hypotheses will need 
to be further investigated to determine their 
feasibility.  
Theoretical COMSOL models were also run 
assuming an arbitrary diffusion coefficient of 
5x10-10 m2/s for all antibiotic concentrations. 
Instead of matching MIC, critical time, and inhibition zone, a new approach was taken. Various time 
intervals were investigated to determine if the relationship of inhibition zone versus antibiotic 
concentration was preserved between experiment and theory. Theoretical inhibition zones were 
standardized using the experimental data from the antibiotic concentration of 50 ug/mL. Standardization 
was achieved by generating surface concertation versus inhibition zone plots for each antibiotic 
concentration and marking the inhibition zone achieved by the 50 ug/mL concentration which was 5.7 
mm when measuring from the center of the channel rather than the edge. The intersecting surface 
concentration was then assigned the MIC. Inhibition zone data from the other antibiotic concentrations 
were determined by locating the intersection of the MIC. These graphs can be seen in Appendix B. The 
new theoretical inhibition zones were then plotted with the experimental inhibition zone data. Upon 
indication that the arbitrary theory was following a similar trend to experimental data, more theoretical 
time points were analyzed to determine the time range at which the theoretical results were within the 
experimental error (Figure 5.6). It is important to note that each theoretical line at a given time point has a 
 
Figure 5.5 Surface Concentration for 50 ug/mL 
Antibiotic Concentration. The red x indicates the 
time point at which the maximum surface 
concentration was reached. The dashed line indicates 








































different MIC. This method resulted in an approximation of both the range of times that fit the 
experimental error and MICs at which these inhibition zones occur at. 
 
5.3 Discussion and Conclusions 
Prior to the creation of the model, it was assumed that the diffusion coefficient would be constant for the 
system regardless of starting antibiotic concentration. However, upon matching a diffusion coefficient to 
each starting antibiotic concentration by finding the intersection of the inhibition zone, critical time, and 
MIC, they were different. This result indicated that if a constant diffusion coefficient assumption was 
true, additional factors must be influencing the results. Initially, it was thought that this difference could 
be due to the faulty boundary condition assumption of accumulation at the surface and maybe 
consumption of antibiotics could account for this difference. The same number of bacteria were initially 
added to each plate, so in order for this theory to prove true, antibiotic flux into the bacteria must be 
related to the concentration of the antibiotics. The higher the antibiotic concentration, the greater the flux. 
It is also possible that the flux is negligible compared to the diffusion of antibiotics and is not contributing 
to this problem at all. 
 
Figure 5.6 Comparison of Theoretical and Experimental Inhibition Zones. Time points at which 































If it was true that flux at the surface was negligible, another explanation could be due to using the faulty 
critical time parameter as previously discussed in Chapter 4. The actual critical time is most likely shorter 
than the time calculated experimentally in this research due to the fact that the calculated critical time 
includes the time it takes the antibiotics to diffuse to the surface as well as the response time of the 
bacteria themselves. When studying the surface concentration versus time outputs calculated with the 
arbitrary diffusion coefficient in COMSOL, the possibility that the maximum surface concentration had 
already occurred and that the system was moving towards equilibrium at the critical time was identified. 
Meaning that the matching process was identifying the second time at which the surface concentration 
approaches the MIC and not the first. Further testing and/or model must be conducted to determine the 
actual cause of the varying diffusion coefficients.  
For the second method, the diffusion coefficient was assumed to be the same. The theoretical models 
were constructed with a constant diffusion coefficient and inhibition zones standardized off of the 50 
ug/mL antibiotic concentration experimental trial. This method utilized an arbitrary diffusion coefficient 
with a goal of determining whether or not a similar relationship between inhibition zone and antibiotic 
concentration could be observed. It turned out that the trend was very similar to the experimental results. 
The time range of which the theory was within error was approximately 100 minutes. The results of this 
arbitrary model were very promising and were an indicator that the bacterial patterning was dominated by 
the antibiotic diffusion process. However, determination of the apparent diffusion coefficient is necessary 







APPLICATIONS OF VASCULARIZED ANTIBIOTIC DELIVERY SYSTEMS 
6.1 Introduction 
With the imminent consequences of global warming and a continually rising global population, Earth’s 
natural resources are dwindling and the sustainability of human life on Earth as we know it is becoming 
threatened. With the rapid development of technology for space travels the prospect of Lunar and Martian 
missions is more promising by day. However, the health risks associated with prolonged travel and 
limited accessibility to healthcare presents a major threat. Due to the close proximity of individuals 
traveling in space and the continual recycling of resources, infections are all too common. What start as 
normal microbial inhabitants of the human body unpredictably mutate into pathogenic, antibiotic resistant 
organisms capable of threatening the health of passengers.58–60 To make things worse, the integrity of 
antibiotics to treat these pathogens is compromised on space missions.58 In this research, we propose a 
simple, fast, and cheap solution to identify antibiotic resistance that is able to function in microgravity. 
This same technology will then be able to be used to create customized treatment plans to combat these 
opportunistic pathogens on space missions. The system was constructed by strategically placing channels 
within a typical agar-based cell culture plate using 3D gel printing techniques. The plate was then 
streaked with a mixed culture of antibiotic resistant microbes and antibiotics inserted into the channels. 
Using these methods, mixed cultures of bacteria were successfully sorted according to antibiotic 
resistance and potential mutant colonies isolated for further analysis. 
6.2 Materials and Methods 
6.2.1 Arbitrary Patterning 
Arbitrary patterning of a biointerface can be used to create bacterial cultures of desired shape and size 




6.2.2 Separation According to Antibiotic Resistance 
A three-channel vascular pattern was encapsulated into an agar matrix according to the procedures 
outlined in Chapter 3. E. coli GFP and B. subtilis stock cultures were individually grown on LB agar 
plates with 5 ug/mL gentamicin sulfate and 100 ug/mL kanamycin sulfate added, respectively, to select 
for their antibiotic resistance genotypes. Next, antibiotics were added to the three channels. Equal parts of 
30 ug/mL gentamicin sulfate and 300 ug/mL kanamycin sulfate were mixed together and added to the left 
channel for resulting concentrations of 15 ug/mL gentamicin sulfate and 150 ug/mL kanamycin sulfate. 
The middle channel was filled with 150 ug/mL kanamycin sulfate and the right channel 15 ug/mL 
gentamicin sulfate. The plates were left to incubate overnight for 18 to 24 hours at 37 ˚C.  
6.2.3 Bacterial Regrowth 
A vascular pattern was encapsulated into an agar matrix according to the procedures outlined in Chapter 
3. Individual plates were streaked with E. coli GFP and S. epidermidis. A concentration of 50 ug/mL 
gentamicin sulfate was added to the S. epidermidis streaked plates and 150 ug/mL kanamycin sulfate to 
the E. coli GFP plates. The plates were incubated for 48 hours at 37 ˚C.  
6.3 Results 
As seen in Figure 6.1, varying degrees and complexity 
of bacterial surface coverage can be achieved through 
varying the channel geometry. Figure 6.2. demonstrates 
the ability to successfully separate bacterial strains of 
varying antibiotic resistances. The channel on the left 
was treated with a combination of gentamicin sulfate and kanamycin sulfate and resulted in no growth on 
the surface above the channel.  The middle channel was treated with kanamycin sulfate and resulted in 
isolated growth of B. subtilis which carried a gene for kanamycin resistance. The right channel was 
treated with gentamicin sulfate and resulted in isolated growth of E. coli GFP. The isolation of growth 
was confirmed using quadrant streak plates as well as fluorescence microscopy to detect the presence of 
 





E. coli GFP. The regrowth of S. epidermidis and E. coli GFP following the depletion of antibiotics can be 
found in figure 6.3.
 
 
Figure 6.3. Bacterial Regrowth Following Antibiotic Treatment. A) S. epidermidis and B) E. coli 
GFP. Red arrows indicate areas where regrowth was observed. 





Figure 6.2. Separation According to Antibiotic Resistance. A) Agar plate is streaked with a mixture 
of E. coli GFP (gentamicin resistant) and B. subtilis (kanamycin resistant). Gentamicin and kanamycin, 
kanamycin, and gentamicin are added to the channels. B) The isolation of B. subtilis was achieved over 
the kanamycin channel and E. coli GFP over the gentamicin channel. No growth was observed over 
the channel with the combination of antibiotics. C) Fluorescence microscopy was used to verify the 













6.4 Discussion and Conclusions 
The ability to arbitrarily pattern a surface using vascular channels is quite useful and simple. This process 
occurs passively as the antibiotics are delivered through diffusion. Precisely controlling when and where 
bacteria grow is key to improving and customizing sample preparation in pursuit of point-of-care 
diagnostic improvements. It has been demonstrated that through the use of strategic geometry and 
antibiotic treatments, bacteria can be separated according to possession of antibiotic resistance genes 
without the use of liquid cultures. As seen in the bacterial regrowth studies, isolated colonies can also be 
achieved to allow for further characterization. With further testing it can be determined if this regrowth is 
attributed to the development of antibiotic resistance or if it is an indication of an already present 
mutation. 
In addition to an increase in passenger safety in prolonged space travels, this technology can be directly 
applied to Earth applications. This technology would be beneficial in other confined and/or isolated 
spaces where humans inhabit for long periods of time and medical attention may not be readily available, 
such as Antarctica research stations. This low cost, simple testing platform can also be used in rural areas 





CONCLUSIONS AND FUTURE DIRECTIONS 
7.1 Review 
This work has resulted in the development of a vascularized bacterial cell culturing platform as a novel 
development in the field of bacterial patterning, which introduce new ways to manipulate bacterial 
samples. This work has established methods to construct and perform proof-of-principle tests on 
vascularized agar bacterial cell culturing systems. Methods for the creation and interpterion of COMSOL 
models were also developed.  
It was shown that arbitrary bacterial surface patterning can be achieved through the insertion of vascular 
channels within the agar, of which deliver bioactive compounds to the biointerface. The precise three-
dimensional positioning of the vascular channels results in the ability to control surface bacterial 
patterning in both a spatial and temporal manner.  
Through characterization of experimental trials with simple vasculature, it was proven possible to create a 
predictive model of much more complex channel geometries. This model was created in COMSOL using 
the transport of diluted species module in a time dependent solver. Experimentally determined parameters 
including inhibition zone, critical time, and MIC were used in the refinement of the model.  
The arbitrary bacterial patterning has proven useful in applications of sorting bacteria according to 
antibiotic resistance. It was also shown that isolated colonies of potential mutants can be achieved.  
7.2 Future Directions 
The discrepancies between our experimental and published MIC values will need to be further 
investigated. Experimental results indicate that our MICs are above 1.5 ug/mL. However, theoretical 
COMSOL models are indicating that a concentration of 1.5 ug/mL is never achieved at the observed 
inhibition zone. New experiments will need to be constructed to determine the MIC and COMSOL 




One very interesting avenue that will be pursued in the future is the difference between the inhibition 
zone of E. coli GFP of the unaided eye and the that observed using fluorescence microscopy. Time lapse 
photos of each system will be used to create a relationship between the two. This will ultimately allow for 
more information to be extracted about critical time and the timing of the different phases of the bacterial 
growth curve. 
The additional data obtained from the fluorescence inhibition zone studies will contribute to the continued 
refinement of the COMSOL models. The COMSOL models have been proposed with one currently 
utilizing an arbitrary apparent diffusion coefficient. However, future work will be necessary to determine 
which model is more likely. The cause for the differing diffusion coefficients in the first model must be 
elucidated and for the second model, the appropriate times and diffusion coefficients must be determined.  
7.3 Summary 
In summary, this work established methods for the creation, characterization, and modeling of bacterial 
patterning on vascularized polymer platforms. Applications such as customizable sample preparation for 
point-of-care diagnostics and detection of antibiotic resistance were discussed. This work presented 
information essential for further development of this platform technology. Potential for this platform 
technology extends beyond bacterial cell culturing and into applications of localized chemical reactions, 
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APPENDIX A. VASCULAR CHANNEL CHARACTERIZATION RAW DATA 
Chapter 4 reported methods of characterizing the bacterial surface patterning parameters of inhibition 
zone, MIC, and critical time. Table A.1. shows the raw inhibition zone measurements for both S. 
epidermidis and E. coli K12. Table A.2. shows the raw data for the MIC experimental trials, and Table 
A.3. the data from the critical time trials. Inhibition zone measurements from the evaporation studies are 
also included in Table A.4. 






Table A.2. Minimum Inhibitory Concentration Agar Plate Method Raw Data. Results indicate 
colony forming unit (CFU) counts and CG indicates confluent growth and inability to distinguish between 
number of CFUs. The hyphen indicates that no trial was performed at the specified antibiotic 





Table A.3. Critical Time Data. Critical times in minutes for S. epidermidis and E. coli wt. 
 
 
Table A.4. Mann-Whitney U-Test. A comparison of channel treatments. 2G indicates grease sealing 














Table A.5. Evaporation Data. 0G indicates no grease, 1G indicates one inlet sealed with grease, and 2G 








APPENDIX B. THEORETICAL MODELING  
Chapter 5 presented two possible theoretical models that were matched to experimental results. Table B.1. 
displays the parameters used in designing the COMSOL theoretical models. The second theoretical model 
inputted a constant diffusion coefficient of 5x10-10 m2/s for antibiotic concentrations. Theoretical 
inhibition zones were generated by standardizing with the inhibition zone of 50 ug/mL antibiotic 
concentration. Figures B.1-3. Display the process of determining the theoretical inhibition zones. For 
these figures it is important to note that rather than a smooth plot, knees are present around 6 and 7.75 
mm due to the resolution of the solver, solutions were generated at 25-minute increments. 







Figure B.1. Standardized Theoretical Inhibition Zones. The lower boundary of error where time 
equals 121 minutes is displayed. 
 
 







Figure B.3. Standardized Theoretical Inhibition Zones. The upper boundary of error where time 
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